Re: Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease, Nokleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P. Vaccine 2007;25(16):3080-4.
Lennon
Diana
D
D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D008589:Meningococcal Infections / Q000382:microbiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology*
D001425:Bacterial Outer Membrane Proteins; D022401:Meningococcal Vaccines